Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can the Peritoneal Cavity be a Source of Regulatory B Cells to Treat Auto-immune Disease?

NCT03189316 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03189316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03189316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can the Peritoneal Cavity be a Source of Regulatory B Cells to Treat Auto-immune Disease?
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Terminated
Start date
June 6, 2017
Completion date
December 13, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal insufficiency, ovarian cysts